An improved method for evaluation of nephrotoxicity by assay of urinary N-acetyl-β-D-glucosaminidase (NAG) activity

Toxicology Methods

Volumn 7, Issue 3, 1997, Pages 153-176

  Hosseini, Rohollah ^a   Dehpour, Ahmad Reza ^a   Rad, Mansour Hashemy ^a   Rankohi, Kobra Elmi ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gel filtration; N acetyl D glucosaminidase; Nephrotoxicity; Reference intervals; Urinary enzyme

Indexed keywords

EID: 0345944845     PISSN: 10517235     EISSN: None     Source Type: Journal    
DOI: 10.1080/105172397243132     Document Type: Article

References (57)

1. Muller PW, Delaney V, MacNeil ML, Caudill SP, Steinberg KK. Indicators of acute renal-transplant rejection in patients treated with cyclosporine. Clin Chem. 1990;36:759-764.
2. Jung K, Diego J, Strobelt V, Scholz D, Schreiberg G. Diagnostic significance of some urinary enzymes for detecting acute rejection crises in renal-transplant recipients: alanine aminopeptidase, alkaline phosphatase, δ-glutamyl-transpeptidase N-acetyl-β-D-glucosaminidase and lysozyme. Clin Chem. 1986;32:1807-1811.
3. Corbett R, Gardner GJ, Kind PRN, Thompson AE, Price RG. Comparison of urinary N-acetyl-β-D-glucosaminidase and urinary fibrin degradation products for diagnosis of rejection after renal transplantation. Clin Chim Acta. 1983;128:141-150.
4. Corbett CRR, Wellwood JM, Tuker SM, Thompson AE. 5-year experience of N-acetyl-β-D-glucosaminidase for diagnosis of rejection in renal transplantation. Transplant Proc. 1979;11:1226.
5. Jung K, Diego J, Scholz D, Schröder K, Strobelt V. Urinary enzyme excretion by renal-transplant recipients in relation to interval after transplantation. Clin Chem. 1982;28:1762-1764.
6. Ellis EN, Brouhard BH, Lagrone L, Travis AB. Urinary excretion of N-acetyl-β-D-glucosaminidase in children with type I diabetes mellitus. Diabetes Care. 1983;6:251-255.
7. Watts GI, Vlitos MAJ, Morris RW, Price RG. Urinary N-acetyl-β-D-glucosaminidase excretion in insulin dependent diabetes mellitus: relation to microalbuminuria, retinopathy and glycaemia control. Diabetes Metab. 1988;14:653-658.
8. Jung K, Pergande M, Schimke E, Ratzmann KP, Ilius A. Urinary enzymes and low-molecular-mass proteins as indicators of diabetic nephropathy. Clin Chem. 1988;34:544-547.
9. Johnston IDA, Jones NF, Scoble JE, Yuen CT, Price RG. The diagnostic value of urinary enzyme measurements in hypertension. Clin Chim Acta. 1983;133:317-325,
10. Alderman MH, Melcher L, Drager DE, Reidenberg MM. Increased excretion of urinary N-acetyl-β-D-glucosaminidase in essential hypertension, and its decline with antihypertensive therapy. N Engl J Med. 1983; 309:1213-1217.
11. Wellwood JM, Lovell D, Thompson AE, Tighe JR. Renal damage caused by gentamicin: a study of the effects on renal morphology and urinary enzyme excretion. J Pathol. 1976;118:171-182.
12. Inouye S, Niizato T, Shomura T, Kitasato I. Nephrotoxicity of dactimicin, a novel pseudo-disaccharide aminoglycoside possessing the N-formimidoyl group, compared with that of astromicin, amikacin, and other aminoglycoside antibiotics in animals. Drugs Exp Clin Res. 1989;15:189-209.
13. Koren G, Klein J, MacLeod SM. The dissociation between aminoglycoside serum concentrations and nephrotoxicity. Life Sci. 1988;43:1817-1823.
14. Newman RA, Weinstok LB, Gump DW, Hacker MP, Yates JW. Effect of osmotic diuresis on gentamicin-induced nephrotoxicity in rats. Arch Toxicol. 1980;45:213-221.
15. Kojima R, Ito M, Suzuki Y. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects, 3: protective effect of latamoxef against tobramycin nephrotoxicity and its protective mechanism. Jpn J Pharmacol. 1986;42:397-404.
16. Kojima R, Ito M, Suzuki Y. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects, 8: protective effect of pyridoxal-5′-phosphate against tobramycin nephrotoxicity. Jpn J Pharmacol. 1990;52:11-21.
17. Kojima R, Ito M, Suzuki Y. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects, 9: protective effect of inositol hexasulfate against tobramycin-induced nephrotoxicity. Jpn J Pharmacol. 1990;53:347-358.
18. Harauchi T, Yoshizaki T. A method for determining urinary enzyme activities as nephrotoxic indicators in rats. Jpn J Pharmacol. 1990;54:205-215.
19. Whiting PH, Petersen J, Simpson JG. Gentamicin-induced nephrotoxicity in mice: protection by loop diuretics. Br J Exp Pathol. 1981;62:200-206.
20. Price RG. Urinary enzymes, nephrotoxicity and renal disease. Toxicology. 1982;23:99-134.
21. Conchie J, Findlay J, Levvy GA. Mammalian glycosidase: distribution in the body. Biochem J. 1959;71:318-325.
22. Bourbouze R, Baumann FC, Bonvalet JP, Farman N. Distribution of N-acetyl-β-D-glucosaminidase isoenzymes along the rabbit nephron. Kidney Int. 1984;25:634-642.
23. Severini G, Alberti LG. Variation of urinary enzymes N-acetyl-β-D-glucosaminidase, alanine aminopeptidase and lysozyme in patients receiving radio-contrast agents. Clin Biochem. 1987;20:239-241.
24. Langhendries TP, Battisti D, Bertrand TM. Aminoglycoside nephrotoxicity and urinary excretion of N-acetyl-β-D-glucosaminidase. Biol Neonate. 1988;53:153-159.
25. Wellwood JM, Ellis BG, Price RG, Hammond K, Thompson AE, Jones NF. Urinary N-acetyl-β-D-glucosaminidase activities in patients with renal disease. Br Med J. 1975;3:408-411.
26. Price RG, Dance N. The excretion of N-acetyl-β-D-glucosaminidase and β-galactosidase following surgery to the kidney. Clin Chim Acta. 1970;27:65-72.
27. Dance N, Price RG, Cattell WR, et al. The excretion of N-acetyl-β-D-glucosaminidase and β-galactosidase by patients with renal disease. Clin Chim Acta. 1970;27:87-92.
28. Lockwood TD, Bosmann HB. The use of urinary N-acetyl-β-D-glucosaminidase in human renal toxicology, II: elevation in human excretion after aspirin and sodium salicylate. Toxicol Appl Pharmacol. 1979;49:337-345.
29. Kunin CM, Chesney RW, Craig WA, et al. Enzymuria as a marker of renal injury and disease: studies of N-acetyl-β-D-glucosaminidase in the general population and in patients with renal disease. Pediatrics. 1978;62:751-760.
30. Tuker SM, Pierce RJ, Price RG. Characterization of human N-acetyl-β-D-glucosaminidase isoenzymes as an indicator of tissue damage in disease. Clin Chim Acta. 1980;102:29-40.
31. Goren MP, Wright RK, Osborn S. Two automated procedures for N-acetyl-β-D-glucosaminidase evaluated for drug-induced tubular nephrotoxicity. Clin Chem. 1986;32:2052-2055.
32. Knoll E, Wisser H, Rautenstrauch H. Comparative study of the diagnostic value of disc electrophoresis of urine proteins and measurement of the excretion of N-acetyl-β-D-glucosaminidase for the detection of renal tubule damage in chronic polyarthritis. J Clin Chem Clin Biochem. 1980;18:53-58.
33. Tuker SM, Boyd PJR, Thompson AE, Price RG. Automated assay of N-acetyl-β-D-glucosaminidase in normal and pathological human urine. Clin Chim Acta. 1975;62:333-339.
34. Bondiou MT, Bourbouze R, Bernard M, Percheron F, Peres-Gonzalez N, Cabezas JA. Inhibition of A and B N-acetyl-β-D-glucosaminidase urinary isoenzymes by urea. Clin Chim Acta. 1985;149:67-73.
35. Muller PW, MacNeil ML, Steinberg KK. N-acetyl-β-D-glucosaminidase: urea inhibition. J Anal Toxicol. 1989;13:188-190.
36. Wellwood JM, Price RG, Ellis BG, Thompson AE. A note on the practical aspects of the assay of N-acetyl-β-D-glucosaminidase in human urine. Clin Chim Acta. 1976;69:85-91.
37. Werner M, Maruhn D, Atoba M. Use of gel filtration in the assay of urinary enzymes. J Chromatogr. 1969;40:254-263.
38. Maruhn D. Rapid colorimetric assay of β-galactosidase and N-acetyl-β-D-glucosaminidase in human urine. Clin Chim Acta. 1976;73:453-461.
39. Horak E, Hopfer SM, Sunderman FW Jr. Spectrophotometric assay for urinary N-acetyl-β-D-glucosaminidase activity. Clin Chem. 1981;27: 1180-1185.
40. Werner M, Gabrielson D. Ultrafiltration for improved assay of urinary enzymes. Clin Chem. 1977;23:700-704.
41. Price RG. Measurement of N-acetyl-β-D-glucosaminidase and its isoenzymes in urine: methods and clinical applications. Eur J Clin Chem Clin Biochem. 1992;30:693-705.
42. Jung K, Klotzek S. More about determination of N-acetyl-β-D-glucosaminidase activity in urine without pretreatment of samples. Clin Chem. 1988;34:1002.
43. Leaback DH, Walker PG. Studies on glucosaminidase, 4: the fluorimetric assay of N-acetyl-β-D-glucosaminidase. Biochem J. 1961;78:151-156.
44. Noto A, Ogawa Y, Moris S, et al. Simple, rapid spectrophotometry of urinary N-acetyl-β-D-glucosaminidase, with use of a new chromogenic substrate. Clin Chem. 1983;29:1713-1716.
45. Makise J, Salto E, Obuchi M, Kanayama M, Harakawa K, Yoshida K. Improved kinetic rate assay of urinary N-acetyl-β-D-glucosaminidase with 2-chloro-4-nitrophenyl-N-acetyl-β-D-glucosaminide as substrate. Clin Chem. 1990;36:319-322.
46. Yagi T, Hisada R, Shibata H. 3,4-Dinitrophenyl-N-acetyl-β-D-glucosaminide, a synthetic substrate for direct spectrophotometric assay of N-acetyl-β-D-glucosaminidase or N-acetyl-β-D-hexosaminidase. Anal Biochem. 1989;183:245-249.
47. Yuen CT, Kind PRN, Price RG, Praill PFG, Richardson AG. Colorimetric assay for N-acetyl-β-D-glucosaminidase (NAG) in pathological urine using the w-nitrostyryl substrate: the development of a kit and the comparison of manual procedure with automated fluorimetric method. Ann Clin Biochem. 1984;21:295-300.
48. Pócsi I, Taylor SA, Richardson AC, Aamlid KH, Smith BV, Price RG. VRA-GlcNAc: novel substrate for N-acetyl-β-D-glucosaminidase applied to assay of this enzyme in urine. Clin Chem. 1990;36:1884-1888.
49. 2M) in evaluating nephrotoxicity of gentamicin. Clin Chim Acta. 1981;171:25-34.
50. Fujita K, Sayama T, Abe S, Murayama T, Tashiro H. Age-dependent aminoglycoside nephrotoxicity. J Urol. 1985;134:596-597.
51. Langhendries JP, Battisi O, Bertrand JM, et al. Once-a-day administration of amikacin in neonates: assessment on nephrotoxicity and ototoxicity. Dev Pharmacol Ther. 1993;20:220-230.
52. Jung K, Grützmann KD. Quality control material for activity determinations of urinary enzymes. Clin Biochem. 1988;21:53-57.
53. Flandrois C, Lahet C, Feldmann D, Gabastou JM, Gonnon A, Malre I. Urinary alanine aminopeptidase assay improved as result of multivariate response-surface. Clin Chem. 1988;34:954-957.
54. Samadian T, Dehpour AR, Amini S, Nouhnejad P. Inhibition of gentamicin-induced nephrotoxicity by litium in rat. Histol Histopathol. 1993; 8:139-147.
55. Stolarek I, Howey JE, Frazer CG. Biological variation of urinary N-acetyl-β-D-glucosaminidase: practical and clinical implications. Clin Chem. 1989;35:560-563.
56. Houser M. The effect of hydropenia and oral water loading on renal lysozyme handling and N-acetyl-β-D-glucosaminidase excretion in man. Ann Clin Biochem. 1986;23:453-457.
57. Lim CW. N-acetyl-β-D-glucosaminidase assay by the p-nitrophenol technique: inhibitory effects of urine as decreased by gel nitration and by simple dilution. Clin Chem. 1987;33:713-714.